The Power of PR + Social

Transforming Complex Technology Into Compelling Stories
Biotech, Blockchain and Beyond
Seattle - Worldwide

The s2s client

Your title is founder, CEO or CMO. You and your startup are complex and evolving. Your passion to commit fully to an idea is unquestionable as you cultivate market share, drive awareness and earn investors.

You’ve launched a startup, demonstrated your proof of concept, and you’re positioning your company to move from seed funding to your series A, seeking media validation and credibility
You’re building local, national, and global awareness to drive investor interest, customer engagement, and talent acquisition
You recognize your leadership team plays a major role in raising awareness of your company as thought leaders, and want to position them as speakers, media sources, and article authors

About s2s

s2s Public Relations is built on transparency, collaboration and results. We serve emerging tech and biotech startups in the Pacific Northwest with our global reach. Our public relations experience offers perspectives from all sides of the public relations equation. We are former major market reporters, startup execs, in-house global public relations and social media leaders, and graduates from traditional big-box public relations agencies.

We’re trusted advisers to emerging tech companies in UW CoMotion Labs and the Founders Live global community. 

W Comotion Your Innovation Partner
Founders Live


Whether you're building awareness to leap frog your startup from seed funding 2 your series A, series A 2 series B, you're powering-up storytelling 2 succeed, or redefining an industry and searching for the right strategic adviser 2 startups, click on the s2s PR Let's Chat button now.

Bio tech



Investment Community


Public Relations

We’ve been generating awareness and activating influencers in the global public relations environment since 2010. We have worked directly with reporters at The Wall Street Journal, Bloomberg Business, Reuters, The Associated Press, NBC News, along with local media such as The Seattle Times and tech media such as Tech Crunch. As a TV news reporter, our founder Eric reported live while embedded with Search and Rescue during hurricanes, shook hands with the Dalai Lama and earned a personal collection of White House press passes. Before launching a boutique communications firm, he managed public relations and social media for a global tech company. The culmination of these experiences provides exceptional tenacity and authenticity in telling your story.

Social Media

We engage traditional and niche media through multiple campaigns and evolving angles. We work collaboratively with your internal team to identify desirable media outlets and develop stories we believe will quickly earn media. We’ll also ensure that we profile, amplify, and leverage your partner relationships, testimonials, and success stories using social media, newsletters, and earned media.

We've organically raised Facebook pages from 5,000 to 500,000 followers through relevant content and an engaging cadence. We target desirable demographic groups, such as key opinion leaders, potential investors, and future partners.

Profile Building

Your company produces two products, what you sell and the influence of your executive team. We harness and direct your internal thought-leadership to power your message, drive awareness and elevate your brand. s2s PR will cultivate potential sponsorships, speaking engagements, and panel discussion opportunities that will place your thought leaders in front of decision makers. Our services include attendance and sponsorship recommendations, award nominations, sourcing and securing speaking engagements, and speech consultation.

Industry Insights and Testimonials

ZME Science ft. Phase Genomics: Saving the Honey Bee: Can New Genomic Clues Help Solve the Colony Collapse Mystery?

Colony collapse disorder has been the scourge of U.S. beekeepers for more than a decade, contributing to a 30-40…

KIVI Boise: New research tracks how bacteria communicate, share DNA to resist antibiotics

BOISE - A growing public health crisis is happening all over the world, including our rivers, soil, and…

PSBJ Interview: Fred Hutch veteran Dr. Carla Grandori is flipping the script on cancer treatment

Grandori's company SEngine, is preparing for a future in which cancer is not going to be treated according…

Medgadget ft. Nu-Med Plus: Miniaturized Inhaled Nitric Oxide Delivery Units for Use in a Doctor’s Office

Nu-Med Plus, a medtech firm based in Utah, has developed a range of smart delivery devices for inhaled…

HOW TO LIVE TO 200 PODCAST features Dr. Ivan Liachko of Phase Genomics, ‘Cat Poop and the Secrets of the Microbiome’

Dr. Ivan Liachko, Founder & CEO of Phase Genomics, recently sat down with the How to Live to…

Study to explore viability of robot-built space outposts made from debris

There's a lot of perfectly good space junk floating around up there, such as the upper stages of…

Seattle Angel Fund rebrands with launch of SeaChange, its largest raise to date

Angel investing is a tricky game. Supporting a startup just getting off the ground takes a lot of…
7-27-2018 PitchBook

s2s PR Representing Xconomy “What’s Hot in Seattle Biotech” Speakers

We're proud to have cultivated the speaking engagement for Phase Genomics. CEO Ivan Liachko will present on the…
4-30-2018 Xconomy

KOMO 4 Appearance: Female Founders Alliance Speaks about Tech and VC Gender Gap

Female Founders Alliance Founder, Leslie Feinzaig speaks with KOMO 4's Mary Nam about the inaugural Champion Awards honoring advocates…
2-12-2018 KOMO 4 ABC NEWS

Testimonial: Opticyte

"s2s PR helped transform our complex medical messaging into a compelling and human story for both investors and…

GeekWire: SEngine Receives 3.1m Grant to Bring Personalized Cancer Fighting Tech to Patients

Every patient’s cancer is unique and every patient responds to cancer drugs differently. But right now, all patients…
5-2-2018 Geekwire

Testimonial: The Vermouth App

Eric went from zero to two TV news crews covering our launch party less than two weeks after…

Testimonial: SEngine Precision Medicine

Eric distilled our complex subject matter, creating and posting compelling content on our social channels including LinkedIn. This…

SEngine Discovery of Common Link in 28% of all Cancers Makes Medical, Life Science News

Scientists from Cure First and SEngine Precision Medicine discover common link in 28% of all cancers Read the…
4-13-2018 Medical Life Science News

Seattle Business Magazine features SEngine Precision Medicine

SEngine Precision Medicine CEO Dr. Carla Grandori showcases SEngine's scientific edge in functional precision oncology:
2-21-2018 Seattle Business Magazine
View Archive
Coming soon
Coming soon